Early Serum Heme Oxygenase-1, Soluble Vascular Endothelial Growth Factor Receptor-1, and B-Cell Lymphoma/Leukemia-2 Levels and Unfavorable Obstetric Outcomes
OBJECTIVE: To examine early pregnancy levels of serum heme oxygenase-1, soluble vascular endothelial growth factor receptor-1, B-cell lymphoma/leukemia-2 in relation to unfavorable pregnancy outcomes, including preeclampsia, fetal growth restriction, spontaneous preterm birth, gestational diabetes...
Saved in:
Main Authors: | Havva Sutcu, G. Fusun Varol, Cihan Inan, Isil Uzun, N.Cenk Sayin |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Network
2022-08-01
|
Series: | Gynecology Obstetrics & Reproductive Medicine |
Subjects: | |
Online Access: | https://gorm.com.tr/index.php/GORM/article/view/1177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heme-Iron OptiFer® in the Treatment of Iron Deficiency Anemia During Pregnancy
by: Ibrahim A. Abdelazim, et al.
Published: (2022-03-01) -
Heme alters biofilm formation in Mycobacterium abscessus
by: Hadia Aftab, et al.
Published: (2025-02-01) -
Is heme biosynthesis influenced the mitochondrial function and cell proliferation in cancer?
by: Raisa Nauli, et al.
Published: (2022-12-01) -
Impact of Varicocele on The Expression of Testicular Enzymes Involved in The Transsulfuration Pathway
by: Azam Shiasi, et al.
Published: (2025-01-01) -
Enhancement of Antioxidant Activity, Stability, and Structure of Heme-Peptides by L-Lysine
by: Yinghui Zhang, et al.
Published: (2025-01-01)